154 related articles for article (PubMed ID: 31400611)
1. Genetic Interaction-Based Biomarkers Identification for Drug Resistance and Sensitivity in Cancer Cells.
Han Y; Wang C; Dong Q; Chen T; Yang F; Liu Y; Chen B; Zhao Z; Qi L; Zhao W; Liang H; Guo Z; Gu Y
Mol Ther Nucleic Acids; 2019 Sep; 17():688-700. PubMed ID: 31400611
[TBL] [Abstract][Full Text] [Related]
2. Harnessing genetic interactions for prediction of immune checkpoint inhibitors response signature in cancer cells.
Liu M; Zhao Z; Wang C; Sang S; Cui Y; Lv C; Yang X; Zhang N; Xiong K; Chen B; Dong Q; Liu K; Gu Y
Cancer Lett; 2024 May; 594():216991. PubMed ID: 38797232
[TBL] [Abstract][Full Text] [Related]
3. A landscape of synthetic viable interactions in cancer.
Gu Y; Wang R; Han Y; Zhou W; Zhao Z; Chen T; Zhang Y; Peng F; Liang H; Qi L; Zhao W; Yang D; Guo Z
Brief Bioinform; 2018 Jul; 19(4):644-655. PubMed ID: 28096076
[TBL] [Abstract][Full Text] [Related]
4. Link synthetic lethality to drug sensitivity of cancer cells.
Wang R; Han Y; Zhao Z; Yang F; Chen T; Zhou W; Wang X; Qi L; Zhao W; Guo Z; Gu Y
Brief Bioinform; 2019 Jul; 20(4):1295-1307. PubMed ID: 29300844
[TBL] [Abstract][Full Text] [Related]
5. Revealing biomarkers associated with PARP inhibitors based on genetic interactions in cancer genome.
Dong Q; Liu M; Chen B; Zhao Z; Chen T; Wang C; Zhuang S; Li Y; Wang Y; Ai L; Liu Y; Liang H; Qi L; Gu Y
Comput Struct Biotechnol J; 2021; 19():4435-4446. PubMed ID: 34471490
[TBL] [Abstract][Full Text] [Related]
6. Inferring synthetic lethal interactions from mutual exclusivity of genetic events in cancer.
Srihari S; Singla J; Wong L; Ragan MA
Biol Direct; 2015 Oct; 10():57. PubMed ID: 26427375
[TBL] [Abstract][Full Text] [Related]
7. A genetic map of the chromatin regulators to drug response in cancer cells.
Chen B; Li P; Liu M; Liu K; Zou M; Geng Y; Zhuang S; Xu H; Wang L; Chen T; Li Y; Zhao Z; Qi L; Gu Y
J Transl Med; 2022 Sep; 20(1):438. PubMed ID: 36180906
[TBL] [Abstract][Full Text] [Related]
8. Ranking novel cancer driving synthetic lethal gene pairs using TCGA data.
Ye H; Zhang X; Chen Y; Liu Q; Wei J
Oncotarget; 2016 Aug; 7(34):55352-55367. PubMed ID: 27438146
[TBL] [Abstract][Full Text] [Related]
9. SynLethDB: synthetic lethality database toward discovery of selective and sensitive anticancer drug targets.
Guo J; Liu H; Zheng J
Nucleic Acids Res; 2016 Jan; 44(D1):D1011-7. PubMed ID: 26516187
[TBL] [Abstract][Full Text] [Related]
10. Pan-Cancer Analysis of Potential Synthetic Lethal Drug Targets Specific to Alterations in DNA Damage Response.
Das S; Camphausen K; Shankavaram U
Front Oncol; 2019; 9():1136. PubMed ID: 31709193
[TBL] [Abstract][Full Text] [Related]
11. Predicting human genetic interactions from cancer genome evolution.
Lu X; Megchelenbrink W; Notebaart RA; Huynen MA
PLoS One; 2015; 10(5):e0125795. PubMed ID: 25933428
[TBL] [Abstract][Full Text] [Related]
12. Whole-Exome Sequencing of Metastatic Cancer and Biomarkers of Treatment Response.
Beltran H; Eng K; Mosquera JM; Sigaras A; Romanel A; Rennert H; Kossai M; Pauli C; Faltas B; Fontugne J; Park K; Banfelder J; Prandi D; Madhukar N; Zhang T; Padilla J; Greco N; McNary TJ; Herrscher E; Wilkes D; MacDonald TY; Xue H; Vacic V; Emde AK; Oschwald D; Tan AY; Chen Z; Collins C; Gleave ME; Wang Y; Chakravarty D; Schiffman M; Kim R; Campagne F; Robinson BD; Nanus DM; Tagawa ST; Xiang JZ; Smogorzewska A; Demichelis F; Rickman DS; Sboner A; Elemento O; Rubin MA
JAMA Oncol; 2015 Jul; 1(4):466-74. PubMed ID: 26181256
[TBL] [Abstract][Full Text] [Related]
13. Gene-expression signature regulated by the KEAP1-NRF2-CUL3 axis is associated with a poor prognosis in head and neck squamous cell cancer.
Namani A; Matiur Rahaman M; Chen M; Tang X
BMC Cancer; 2018 Jan; 18(1):46. PubMed ID: 29306329
[TBL] [Abstract][Full Text] [Related]
14. Focal Recurrent Copy Number Alterations Characterize Disease Relapse in High Grade Serous Ovarian Cancer Patients with Good Clinical Prognosis: A Pilot Study.
Dugo M; Devecchi A; De Cecco L; Cecchin E; Mezzanzanica D; Sensi M; Bagnoli M
Genes (Basel); 2019 Sep; 10(9):. PubMed ID: 31491988
[TBL] [Abstract][Full Text] [Related]
15. Individualized genetic network analysis reveals new therapeutic vulnerabilities in 6,700 cancer genomes.
Liu C; Zhao J; Lu W; Dai Y; Hockings J; Zhou Y; Nussinov R; Eng C; Cheng F
PLoS Comput Biol; 2020 Feb; 16(2):e1007701. PubMed ID: 32101536
[TBL] [Abstract][Full Text] [Related]
16. IL-7 Receptor Mutations and Steroid Resistance in Pediatric T cell Acute Lymphoblastic Leukemia: A Genome Sequencing Study.
Li Y; Buijs-Gladdines JG; Canté-Barrett K; Stubbs AP; Vroegindeweij EM; Smits WK; van Marion R; Dinjens WN; Horstmann M; Kuiper RP; Buijsman RC; Zaman GJ; van der Spek PJ; Pieters R; Meijerink JP
PLoS Med; 2016 Dec; 13(12):e1002200. PubMed ID: 27997540
[TBL] [Abstract][Full Text] [Related]
17. SLOAD: a comprehensive database of cancer-specific synthetic lethal interactions for precision cancer therapy via multi-omics analysis.
Guo L; Dou Y; Xia D; Yin Z; Xiang Y; Luo L; Zhang Y; Wang J; Liang T
Database (Oxford); 2022 Aug; 2022():. PubMed ID: 36029479
[TBL] [Abstract][Full Text] [Related]
18. SL-BioDP: Multi-Cancer Interactive Tool for Prediction of Synthetic Lethality and Response to Cancer Treatment.
Deng X; Das S; Valdez K; Camphausen K; Shankavaram U
Cancers (Basel); 2019 Oct; 11(11):. PubMed ID: 31671773
[TBL] [Abstract][Full Text] [Related]
19. IMPACT: a whole-exome sequencing analysis pipeline for integrating molecular profiles with actionable therapeutics in clinical samples.
Hintzsche J; Kim J; Yadav V; Amato C; Robinson SE; Seelenfreund E; Shellman Y; Wisell J; Applegate A; McCarter M; Box N; Tentler J; De S; Robinson WA; Tan AC
J Am Med Inform Assoc; 2016 Jul; 23(4):721-30. PubMed ID: 27026619
[TBL] [Abstract][Full Text] [Related]
20. Identification of Potential Crucial Genes and Key Pathways in Breast Cancer Using Bioinformatic Analysis.
Deng JL; Xu YH; Wang G
Front Genet; 2019; 10():695. PubMed ID: 31428132
[No Abstract] [Full Text] [Related]
[Next] [New Search]